SCHEMBL2409641

SCHEMBL2409641

C[C@@](O)(CCC(=O)O)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAALAD2 Q9Y3Q0 1/20 0.52
ALDH1A1 P00352 4/20 0.48
MEN1 O00255 1/20 0.48
CYP1A2 P05177 1/20 0.48
THRB P10828 1/20 0.48
KMT2A Q03164 1/20 0.48
TSHR P16473 4/20 0.45
TET2 Q6N021 1/20 0.44
HMGCR P04035 1/20 0.43
CHRM1 P11229 1/20 0.43
TBXA2R P21731 1/20 0.43
ADRA1A P35348 1/20 0.43
LMNA P02545 4/20 0.42
ALKBH5 Q6P6C2 1/20 0.42
SUCNR1 Q9BXA5 1/20 0.42
EGLN1 Q9GZT9 1/20 0.42
ESR1 P03372 1/20 0.42
CYP3A4 P08684 1/20 0.42
ESR2 Q92731 1/20 0.42
HIF1A Q16665 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2411890 1.00 NAALAD2 (0.52) NAALAD2ALDH1A1MEN1CYP1A2THRB
SCHEMBL2410928 1.00 NAALAD2 (0.52) NAALAD2ALDH1A1MEN1CYP1A2THRB
SCHEMBL7086369 0.84 LMNA (0.48) NAALAD2ALDH1A1MEN1KMT2ATSHR
Succinic Acid SCHEMBL3145429 0.82 FFAR3 (0.48) NAALAD2ALDH1A1MEN1CYP1A2THRB
SCHEMBL6054231 0.82 ALDH1A1 (0.56) NAALAD2ALDH1A1MEN1CYP1A2THRB
SCHEMBL2331455 0.80
SCHEMBL381314 0.80
SCHEMBL7964223 0.79 NAALAD2 (0.44) NAALAD2ALDH1A1MEN1CYP1A2THRB
SCHEMBL68460 0.78 NAALAD2 (0.52) NAALAD2ALDH1A1MEN1CYP1A2THRB
SCHEMBL11307948 0.78 TSHR (0.55) NAALAD2ALDH1A1MEN1CYP1A2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011106546-A1 A PROCESS FOR THE PREPARATION OF ROSUVASTATIN INTERMEDIATE TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2011-09-01 WO disclosed